Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Reaffirmed by Mizuho themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 10,670,000 shares, a decline of 11.3% from the January 15th total of 12,030,000 shares. Based on an average daily trading volume, of 2,100,000 shares, the days-to-cover […]
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jacob Asset Management of New York LLC raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 1,017.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,850 shares of the company’s stock after buying an additional 4,416 shares during the quarter. […]
Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives Average Rating of Moderate Buy from Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.